secwatch.observer — SEC 8-K summary
======================================

Issuer:     eFFECTOR Therapeutics, Inc. (—)
CIK:        0001828522
Form:       8-K
Filed at:   2023-05-19T23:59:59+00:00
Accession:  0001193125-23-149500
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

eFFECTOR receives Nasdaq notice for stockholders' deficit; faces delisting risk
-------------------------------------------------------------------------------

- Stockholders' deficit of $4.8M as of March 31, 2023; below $2.5M minimum required for continued listing.
- Company also fails alternative compliance standards based on market value of securities or net income.
- Must submit a plan to Nasdaq by July 3, 2023 to regain compliance; extension up to 180 days possible.
- No immediate effect on trading; if plan rejected or non-compliance continues, securities may be delisted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828522/000119312523149500/0001193125-23-149500-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828522/000119312523149500/d504663d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-149500

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer